Handan Kaygun

Handan Kaygun has a diverse work experience spanning over various roles and companies. Most recently, in 2022, they served as an Associate Director for Global Clinical Operations at Daiichi Sankyo, Inc. Prior to that, in 2021, they held positions at GSK as the Global Study Delivery Lead in the Oncology, Cell and Gene Therapy division and as the Local Delivery Lead in the same field. From 2019 to 2021, they worked as a Project Manager for Syneos Health on behalf of GSK. Before that, from 2017 to 2019, they served as a Clinical Team Manager for PRA Health Sciences on behalf of Merck.

In earlier positions, Handan worked as a Global Regulatory and Start-Up Lead and later as a Regulatory and Start-Up Lead at QuintilesIMS from 2015 to 2017. From 2014 to 2015, they were a Clinical Trial Specialist at PAREXEL. Handan's earlier experiences include roles as a Clinical Research Coordinator at UNC Diabetes Care Center from 2011 to 2014, a Clinical Fellow at Carolina Institute of Nanotechnology and Carolina Center of Cancer Nanotechnology Excellence in 2010, and a Senior Scientist at Qualyst Transporter Solutions, LLC from 2008 to 2010. They also held positions as a Postdoctoral Fellow and Research/Teaching Assistant at the University of North Carolina at Chapel Hill from 1999 to 2008.

Overall, Handan Kaygun's work experience demonstrates expertise and leadership in clinical operations, project management, and regulatory affairs within the pharmaceutical and healthcare industry.

Handan Kaygun completed a Bachelor's degree in Molecular Biology and Genetics from Boğaziçi University from 1992 to 1998. Handan then pursued a Doctor of Philosophy (Ph.D.) in Molecular Biology from the University of North Carolina at Chapel Hill, graduating between 1999 and 2005. In 2010 and 2011, they obtained a Certificate in Clinical Research Conduct and Management from UC Berkeley Extension.